+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 19Years +
All Genders
ID04416581

Comparing Tegoprazan 50 mg and Rabeprazole 20 mg for Preventing Upper Gastrointestinal Bleeding in Patients Using Blood Thinners

Led by Duk-Woo Park, MD · Updated on 2026-08-28

3320

Participants Needed

45

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are assessing the safety and effectiveness of a new drug called tegoprazan a Potassium-Competitive Acid Blocker, P-CAB compared to a standard proton pump inhibitor PPI, rabeprazole, in protecting the stomach and upper digestive tract from bleeding and ulcers. This study involves patients who have heart and vascular diseases and use blood-thinning medications that increase the risk of gastrointestinal GI bleeding. The goal is to determine if tegoprazan is at least as good as rabeprazole over a 12-month period. The study has two main parts. First, a safety surveillance phase enrolls about 300 patients taking tegoprazan daily for six months to monitor for liver issues, increased stomach acid hormone levels, or infections. Then, the main randomized phase will include over 3,300 patients assigned to either tegoprazan 50 mg once daily with placebo rabeprazole or rabeprazole 20 mg once daily with placebo tegoprazan. Both groups will be followed for 12 months while taking their assigned medications. Participants will be regularly checked for GI events like bleeding, ulcers, and stomach pain, as well as cardiovascular events such as heart attack or stroke. The study measures when these events first occur and tracks side effects. Safety is closely monitored through lab tests, symptoms, and medical imaging when needed. The entire trial spans several years, with participants involved for at least 12 months during treatment and follow-up.

CONDITIONS

Brief Title

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Research Team

J

Jeong-youn Bae, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here